Lv52
1200 积分 2023-08-04 加入
Hepatotoxicity in the Era of Precision Medicine: Toxicological Mechanisms and Management of Immune and Cell Therapy-Induced Liver Injury
59分钟前
已完结
A proposed modification to Hy's law and Edish criteria in oncology clinical trials using aggregated historical data
1天前
已完结
Obinutuzumab Pretreatment as a Novel Approach to Mitigate Formation of Anti-Drug Antibodies Against Cergutuzumab Amunaleukin in Patients with Solid Tumors
15天前
已完结
CD20-TCB with Obinutuzumab Pretreatment as Next-Generation Treatment of Hematologic Malignancies
15天前
已完结
Antitumor Cytotoxic Activity Retained in Tolerized T Cells Following Daily Dose Escalation of a T-Cell Engager in Cynomolgus Monkeys to Mitigate Cytokine Release Syndrome
18天前
已完结
Cytokine release syndrome risk model with T-cell engaging therapies
23天前
已完结
The Drug-Dosing Conundrum in Oncology - When Less Is More
25天前
已完结
Improving Dose-Optimization Processes Used in Oncology Drug Development to Minimize Toxicity and Maximize Benefit to Patients
25天前
已完结
Backfill Bayesian Ordered Lattice Design for Phase I Clinical Trials
29天前
已完结
皖公网安备34019202002308
